CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
about
Immunological Evasion in GlioblastomaTargeting immune checkpoints in malignant gliomaImmunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Myeloid-derived suppressor cells in gliomas.Pilot Study of Whole Blood MicroRNAs as Potential Tools for Diffuse Low-Grade Gliomas Detection.Immune microenvironment of gliomas.Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotypeConcepts in glioma immunotherapy.Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy.Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas.CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion.Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach.A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial.Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiation.Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival.CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
P2860
Q26746612-923CB907-D599-4D1E-B73B-621A4E822626Q28072012-E98A19EA-FB99-447D-9D22-443F0964ED2FQ28078539-F1CB8275-F034-4B84-8C3A-3D70855F9339Q37727645-51E061F9-534A-4532-BAD9-7CEC6E614282Q38621047-0FACA0B5-49F9-4086-B0DF-3D94B709FD7BQ38712457-C8DC3AD3-1A9B-4557-89D2-D1188A9E4EC3Q38868808-A79A3D90-B357-4DBC-B165-EB514E53D114Q38909071-8CB7D257-CF13-46A4-B1F2-F0E090ED4DC3Q38989773-73EFA0CD-2D0F-4315-93CE-9FE48001A377Q47135965-5562FAF2-621E-44B2-935D-9BF14ACC9F26Q49569708-38AB05AB-5F5A-4CAF-B980-C5E4AE818FDCQ52365121-BDC1956E-3DB1-4F22-AA21-9BE1ACAB84B9Q54980235-C980B458-63E7-4E35-84A7-F3424A20E0E7Q55315483-36A8F499-41D6-4ACB-94EF-894AD6BA7BBCQ55456894-759FDEC7-5C7F-4F22-A6D5-4C0E6CDFA271Q57291659-11EFE936-423D-4C71-92FD-4A2281F4D1B5
P2860
CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CD4+ T effector memory cell dy ...... ells in glioblastoma patients.
@en
type
label
CD4+ T effector memory cell dy ...... ells in glioblastoma patients.
@en
prefLabel
CD4+ T effector memory cell dy ...... ells in glioblastoma patients.
@en
P2093
P2860
P50
P356
P1433
P1476
CD4+ T effector memory cell dy ...... ells in glioblastoma patients.
@en
P2093
Daniel Dubinski
Johannes Wölfer
Oliver M Grauer
Walter Stummer
P2860
P304
P356
10.1093/NEUONC/NOV280
P577
2015-11-17T00:00:00Z